Exhibit 99.1

                              For Immediate Release
                              ---------------------

           Balchem Corporation Announces Stock Split and Cash Dividend

New Hampton,  New York.  December 11, 2009. Balchem Corporation  (NASDAQ:  BCPC)
today announced that its Board of Directors has voted to approve a 3-for-2 stock
split, to be effected in the form of a stock dividend,  and also a cash dividend
of $0.11 per share. For purposes of the cash dividend, the number of outstanding
shares  of Common  Stock to which it will  apply  will give  effect to the stock
dividend.  Both dividends will be payable on January 20, 2010 to stockholders of
record as of December 30, 2009.

Pursuant to the stock dividend,  a stockholder will receive one additional share
of Common  Stock for every two shares of Balchem  Common Stock held of record on
December 30,  2009.  Stockholders  will also  receive  $0.11 per share of Common
Stock on a post stock split basis.  Stockholders  entitled to fractional  shares
resulting from the stock  dividend will receive cash in lieu of such  fractional
shares  based upon the closing  price of  Balchem's  Common  Stock on the record
date.  The stock  split,  to be  effected by means of the stock  dividend,  will
increase the number of Common Shares outstanding from  approximately  18,680,781
to 28,021,172 shares.

Dino A. Rossi, Chairman,  President and CEO of Balchem,  stated: "This action by
the Board of Directors  recognizes the company's quality  financial  performance
and the Board's  confidence in the  management to continue  delivering  positive
results. The cash dividend represents an increase of 50 percent over last year's
dividend, rewarding our shareholders, while preserving the financial flexibility
to explore growth opportunities. The stock dividend will improve the opportunity
to add liquidity and appeal for our stock,  providing  enhanced value to Balchem
shareholders."

Segment Information
Balchem Corporation consists of three business segments: ARC Specialty Products;
Food,  Pharma and  Nutrition;  and Animal  Nutrition  and  Health.  Through  ARC
Specialty  Products,  Balchem provides  specialty-packaged  chemicals for use in
healthcare and other industries. The Food, Pharma and Nutrition segment provides
proprietary  microencapsulation,  granulation and  agglomeration  solutions to a
variety  of  applications  in  the  human  food,  pharmaceutical  and  nutrition
marketplaces.  The Animal Nutrition and Health segment manufactures and supplies
products to numerous animal health markets and certain derivative  products into
industrial applications.

Forward Looking Statements
This  release  contains  forward-looking  statements,  which  reflect  Balchem's
expectation  or  belief   concerning   future  events  that  involve  risks  and
uncertainties.  Balchem can give no assurance that the expectations reflected in
forward  looking  statements  will prove correct and various factors could cause
results to differ  materially from Balchem's  expectations,  including risks and
factors  identified  in Balchem's  annual report on Form 10-K for the year ended
December 31, 2008. Forward-looking statements are qualified in their entirety by
the above cautionary statement. Balchem assumes no duty to update its outlook or
other forward-looking statements as of any future date.

For More Information:
Karin McCaffery, Executive Administration Manager
Telephone:  845-326-5600
e-mail:  kmccaffery@balchem.com